Abstract
Families of cyclin-like proteins have emerged that bind and activate cyclin dependent kinases (Cdk)s, directing the phosphorylation of noncanonical Cdk substrates. One of these proteins, Spy1, has demonstrated the unique ability to directly bind and activate both Cdk1 and Cdk2, as well as binding and promoting the degradation of at least one Cdk inhibitor, p27(Kip1). Spy1 accelerates somatic cell growth and proliferation and is implicated in a number of human cancers including the breast, brain and liver. Herein we isolate key residues mediating the direct interaction with p27. We use mutants of Spy1 to determine the physiological role of direct interactions with distinct binding partners Cdk2 and p27. We demonstrate that disrupting the direct interaction with either Spy1 binding partner decreased endogenous activity of Cdk2, as well as Spy1-mediated proliferation. However, only the direct interaction with p27 was essential for Spy1-mediated effects on p27 stability. In vivo neither mutation completely prevented tumorigenesis, although each mutation slowed the rate of Spy1-mediated tumorigenesis and decreased overall tumor volumes. This work supports the conclusion that direct interaction with both p27 and Cdk2 contribute to Sp...Continue Reading
References
Apr 1, 1995·Carcinogenesis·T K Said, D Medina
Jun 17, 1993·Nature·H L De BondtS H Kim
Oct 6, 1997·The EMBO Journal·J VlachB Amati
May 14, 1999·Genes & Development·A MontagnoliM Pagano
May 1, 2002·The Journal of Cell Biology·Lisa A PorterDaniel J Donoghue
Jul 26, 2002·The Journal of Biological Chemistry·Danielle SitryAvram Hershko
Mar 15, 2003·Bioscience Reports·Paul M Nurse
Sep 16, 2003·Molecular Biology of the Cell·Lisa A PorterDaniel J Donoghue
Apr 15, 2004·Journal of Mammary Gland Biology and Neoplasia·A AlkarainJ Slingerland
Sep 29, 2004·The Journal of Biological Chemistry·Wei WangXuedong Liu
Dec 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·I ZucchiR Dulbecco
Dec 22, 2004·Cell Cycle·Aiyang ChengMark J Solomon
Jun 28, 2005·The Journal of Biological Chemistry·Dana UngermannovaXuedong Liu
Sep 30, 2005·BMC Biochemistry·Aiyang ChengMark J Solomon
Sep 5, 2006·The Journal of Biological Chemistry·Randy F GastwirtDaniel J Donoghue
Apr 6, 2007·Cancer Research·Patrick CorsinoBrian Law
Aug 3, 2007·Cell Cycle·Christopher W McAndrewDaniel J Donoghue
Dec 7, 2007·Trends in Pharmacological Sciences·Marcos MalumbresJames R Bischoff
Mar 29, 2008·Cell Stem Cell·Bryan E WelmZena Werb
May 17, 2008·Cancer Research·Azadeh GolipourLisa A Porter
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Maria Virginia C L AppleyardAlastair M Thompson
Dec 5, 2008·The Journal of Biological Chemistry·Mohammad Al SorkhyLisa A Porter
Aug 19, 2009·Experimental and Molecular Pathology·Qing KeAiguo Shen
Aug 13, 2011·Breast Cancer Research : BCR·Binoj C NairRatna K Vadlamudi
Jan 28, 2012·BMC Cancer·Mohammad Al SorkhyLisa A Porter
Mar 27, 2012·Journal of Molecular Neuroscience : MN·Li ZhangChun Cheng
Apr 12, 2012·Medical Oncology·Qinglei HangSong He
Mar 9, 2013·Nature Biotechnology·Malini Guha
Citations
Jan 14, 2016·Cell Cycle·Matthew R Dewhurst, Philipp Kaldis
Jul 7, 2012·Biomaterials·Nicolynn E DavisMagali J Fontaine
Jul 2, 2017·The EMBO Journal·Denise A McGrathSeth M Rubin
Apr 21, 2017·Oncotarget·Rosa-Maria FerraiuoloLisa Ann Porter
Dec 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Zhaowei TuKui Liu
Mar 8, 2021·Trends in Cell Biology·Marina BuryFrédéric Lessard